FairWarning reports that "Tobacco giant R.J. Reynolds, the top seller of the menthol cigarettes favored by most black smokers, is seizing on the hot button issue of police harassment of blacks to counter efforts by public health advocates to restrict menthol sales." The full story is here.
Category Archives: Uncategorized
This article by LA Times reporter Jim Puzzanghera explains how congressional democrats are planning to defend the Dodd-Frank financial reform litigation from serious incursions or repeal.
Go, for instance, here and here. Update: The Consumerist has this nice explanation.
February 2, 2017 – New York Salesman Sentenced to Prison for Fraudulently Selling Vending Machine Businesses February 1, 2017 – United States Files Enforcement Action Against Florida Company and Senior Managers to Stop the Adulteration and Misbranding of Medicated Animal Feeds January 31, 2017 – Three Individuals Arrested and Charged in South Dakota Fraudulent Medical […]
Federal Trade Commission announced today that Jessica Rich, Director of the Bureau of Consumer Protection, is leaving the agency on February 17, after 26 years of service. The press release is here.
The petition for review, filed in the DC Circuit, is here. Press release here. Excerpt from the press release: “We’re optimistic that the Court will rein in the FTC’s dangerous and irresponsible abuse of its authority. Instead of protecting consumers, the FTC is protecting unscrupulous auto dealers who engage in false and deceptive advertising about […]
Here (behind paywall). Net neutrality is in danger.
In the New York Times today, Paul Krugman discusses the "fiduciary rule" that the President last week ordered the Department of Labor to "reconsider." Last week Mr. Trump released a memorandum calling on the Department of Labor to reconsider its new “fiduciary rule,” which requires financial advisers to act in their clients’ best interests — […]
This article by Melody Peterson explains that a Trump Administration, with the agreement of Congress, may expand a trend in which the Food and Drug Administration cares less about certain drugs' effectiveness than it used to. Here's an excerpt concerning the views of someone Trump is considering to lead the FDA: One of Trump’s possible selections […]
This blog is focused on consumer policy, but I figured that some of our readers may be interested in having ready access to the key litigation documents in Washington State's case against the president over the travel ban. So, here is the the State of Washington's complaint, the State of Washington's request for a temporary restraining […]